In Pain relief Ibupara Plus Syrup relieves pain, reduce swelling and ease inflammation in conditions like rheumatoid arthritis, osteoarthritis and ankylosing spondolytis. It also helps to manage short term symptoms such as muscle and back pain, toothache, or pain in the ear and throat if taken when the first sign of pain occurs. It also prevents acidity that might have occur due to the painkillers present in the medicine. Ibupara Plus Syrup works quickly, usually within a few hours. Take it as prescribed to get the most benefit.
It is unsafe to consume alcohol with Ibupara Plus Syrup.
Ibupara Plus Syrup may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Ibupara Plus Syrup during breastfeeding is not available. Please consult your doctor.
Ibupara Plus Syrup does not usually affect your ability to drive.
Ibupara Plus Syrup should be used with caution in patients with kidney disease. Dose adjustment of Ibupara Plus Syrup may be needed. Please consult your doctor. Use of Ibupara Plus Syrup is not recommended in patients with severe kidney disease. Long term use of this medicine can affect the kidney function.
Ibupara Plus Syrup should be used with caution in patients with liver disease. Dose adjustment of Ibupara Plus Syrup may be needed. Please consult your doctor. However, the use of Ibupara Plus Syrup is not recommended in patients with severe liver disease and active liver disease.
If you miss a dose of Ibupara Plus Syrup, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Croford Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Anrose Pharma Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Spire Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Briskon Laboratories || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Red Bross Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Pharmasynth Formulations Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Medoz Pharmaceutical Pvt. Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Oyster Labs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Oyster Labs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Acron Pharmaceuticals || ₹14.5/tablet (25% cheaper)